Richard Brudnick Prime Medicine, Inc. (PRME) insider trading activity

Richard Brudnick is Chief Business Officer of Prime Medicine, Inc.. Currently has a direct ownership of 20,000 shares of PRME, which is worth approximately $25,400. The most recent transaction as insider was on May 20, 2025, when has been sold 20,000 shares (Common Stock) at a price of $1.19 per share, resulting in proceeds of $23,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20K

n/a 3M change

n/a 12M change

Total Value Held $25,400

Richard Brudnick Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 20 2025	BUY Open market or private purchase	$23,800 $1.19 p/Share	20,000 Added 50.0%	20,000 Common Stock

Also insider at

CDAK

Codiak BioSciences, Inc. Healthcare

Officer

VNRX

VOLITIONRX LTD Healthcare

SRRK

Scholar Rock Holding Corp Healthcare